EULAR 2010 Gout Highlights From Jonathan Kay, MD - Medscape

EULAR 2010 Gout Highlights From Jonathan Kay, MD Medscape They looked at 28 gout patients with a serum uric acid level of ≥ 9 mg/dL. Patients were treated with allopurinol 300 mg taken by mouth daily for 1 week, ...

EULAR: Febuxostat Bests Allopurinol in Gout - MedPage Today

EULAR: Febuxostat Bests Allopurinol in Gout MedPage Today ROME -- Gout patients treated with febuxostat (Uloric) at a dose of 80 mg or 120 mg daily saw greater declines in serum urate levels than those treated with ... EULAR: Canakinumab Prevents Flares in Gout PatientsMedPage Today all 8 news articles »

Febuxostat Appears to Outperform Allopurinol in Percentage of Gout Patients ... - DG News

Febuxostat Appears to Outperform Allopurinol in Percentage of Gout Patients ... DG News "Achievement and maintenance of goal-range serum urate did not occur in many gout patients treated with allopurinol at the most commonly used dose of 300 ... and more »

CORRECT: Ardea Announces Additional Positive Results On Gout Drug - Wall Street Journal

CORRECT: Ardea Announces Additional Positive Results On Gout Drug Wall Street Journal In the study of 123 gout patients, 60% had a positive response when treated with the drug alone. And in a Phase1b study, the drug showed a 100% response ... Ardea touts good gout drug candidate study resultsBusinessWeek Positive Phase 2 Data on RDEA594, Ardea Biosciences' Lead Product Candidate ...PR Newswire (press release) all 34 news articles »